Pulmonary embolism: clinical findings were not very helpful for diagnosis.
|
|
|
Clinical bottom line (level 1b)
-
Around a fifth of patients with pleuritic pain had a pulmonary embolism.
-
No individual clinical sign or symptom was good enough to rule in or rule out pulmonary embolism. Thus clinicians need a high level of suspicion to consider it as a diagnosis and further tests are needed.
|
|
Hull et al:
Archives of Internal Medicine
1988;
148:
838-844
|
Expires
October 2003
|
The study
Setting: emergency departments, two hospitals, Canada
173 patients
(aged
range 17 to 88 years; mean 47,
55%
female)
consecutive outpatients with pleuritic chest pain
Excluded if
dye allergy
critically ill with known primary cardiorespiratory disorder
Independent blinded
reference standard, applied in
all
patients from a
consecutive appropriate
spectrum.
Reference standard:
- Either of
- v/q scan - if abnormal had pulmonary angiogram within 72 hours
- autopsy
No PE if normal v/q scan and negative angiogram.
Diagnostic test:
- history and physical and chest X-ray by one physician
- IPG, if positive confirmed by venogram
The evidence
pre-test probability of pulmonary embolism:
21%,
(95% CI:
15% to
27%)
| diagnostic test |
pulmonary embolism |
no pulmonary embolism |
LR+ (95% CI) |
post-test probability |
LR- (95% CI) |
post-test probability |
| initial symptoms: 40 years old or more |
30 |
76 |
1.5
(1.2 to
1.9)
|
28% |
0.37
(0.18 to
0.80)
|
9% |
| central chest pain |
3 |
21 |
0.5
(0.17 to
1.7)
|
13% |
1.1
(0.96 to
1.2)
|
22% |
| dyspnoea at rest |
22 |
65 |
1.3
(0.94 to
1.8)
|
25% |
0.74
(0.48 to
1.2)
|
16% |
| dyspnoea on mild-to-moderate exertion |
28 |
73 |
1.5
(1.2 to
1.9)
|
28% |
0.48
(0.25 to
0.90)
|
11% |
| haemoptysis |
8 |
21 |
1.5
(0.70 to
3.0)
|
28% |
0.92
(0.76 to
1.1)
|
19% |
| syncope |
3 |
6 |
1.9
(0.50 to
7.2)
|
33% |
0.96
(0.86 to
1.1)
|
20% |
| pleural friction rub |
5 |
13 |
1.5
(0.56 to
3.8)
|
28% |
0.95
(0.83 to
1.1)
|
20% |
| raised jugular venous pressure |
1 |
5 |
0.8
(0.09 to
6.3)
|
17% |
1.0
(0.94 to
1.1)
|
21% |
| central cyanosis |
1 |
4 |
1.0
(0.11 to
8.3)
|
20% |
1.0
(0.94 to
1.1)
|
21% |
| respiratory rate > 20 per min |
27 |
62 |
1.7
(1.3 to
2.2)
|
30% |
0.46
(0.25 to
0.82)
|
11% |
| use of accessory muscles |
6 |
15 |
1.5
(0.64 to
3.6)
|
29% |
0.94
(0.80 to
1.1)
|
20% |
| chest wall tenderness |
4 |
28 |
0.5
(0.20 to
1.5)
|
13% |
1.1
(0.97 to
1.3)
|
23% |
| left parasternal heave |
0 |
1 |
0.0
( to
)
|
0% |
1.0
(0.99 to
1.0)
|
21% |
| abnormal chest examination |
22 |
63 |
1.3
(0.97 to
1.8)
|
26% |
0.72
(0.46 to
1.1)
|
16% |
| total |
36 |
137 |
| diagnostic test |
pulmonary embolism |
no pulmonary embolism |
LR+ (95% CI) |
post-test probability |
LR- (95% CI) |
post-test probability |
| other findings: history of DVT |
9 |
21 |
1.6
(0.82 to
3.3)
|
30% |
0.89
(0.72 to
1.1)
|
19% |
| history of PE |
5 |
15 |
1.3
(0.49 to
3.3)
|
25% |
0.97
(0.84 to
1.1)
|
20% |
| surgery in last 6 months |
12 |
26 |
1.8
(0.99 to
3.1)
|
32% |
0.82
(0.64 to
1.1)
|
18% |
| pelvic surgery |
4 |
10 |
1.5
(0.51 to
4.6)
|
29% |
0.96
(0.85 to
1.1)
|
20% |
| other surgery |
8 |
16 |
1.9
(0.89 to
4.1)
|
33% |
0.88
(0.73 to
1.1)
|
19% |
| cancer |
8 |
8 |
3.8
(1.5 to
9.4)
|
50% |
0.83
(0.69 to
0.99)
|
18% |
| inflammatory or infectious condition |
6 |
18 |
1.3
(0.54 to
3.0)
|
25% |
0.96
(0.82 to
1.1)
|
20% |
| ischaemic heart disease |
7 |
24 |
1.1
(0.52 to
2.4)
|
23% |
0.98
(0.82 to
1.2)
|
20% |
| COPD |
3 |
13 |
0.9
(0.26 to
2.9)
|
19% |
1.0
(0.91 to
1.1)
|
21% |
| CCF |
2 |
6 |
1.3
(0.27 to
6.0)
|
25% |
0.99
(0.91 to
1.1)
|
21% |
| temperature > 38 C |
0 |
3 |
0.0
( to
)
|
0% |
1.0
(1.0 to
1.1)
|
21% |
| white cell count >10 |
19 |
42 |
1.7
(1.2 to
2.6)
|
31% |
0.68
(0.47 to
0.98)
|
15% |
| abnormal chest X-ray |
24 |
58 |
1.6
(1.2 to
2.1)
|
29% |
0.58
(0.36 to
0.94)
|
13% |
| IPG positive |
10 |
3 |
13
(3.7 to
44)
|
77% |
0.74
(0.60 to
0.91)
|
16% |
| total |
36 |
137 |
| diagnostic test |
pulmonary embolism |
no pulmonary embolism |
LR+ (95% CI) |
post-test probability |
LR- (95% CI) |
post-test probability |
| predisposing factor |
23 |
61 |
1.3
(0.98 to
1.8)
|
27% |
0.67
(0.40 to
1.1)
|
16% |
| predisposing factor or suspected DVT |
26 |
70 |
1.3
(1.0 to
1.6)
|
27% |
0.58
(0.30 to
1.1)
|
14% |
| predisposing factor, suspected DVT, or pleural effusion |
29 |
74 |
1.4
(1.1 to
1.7)
|
28% |
0.39
(0.17 to
0.92)
|
10% |
| in patients < 40 predisposing factor, suspected DVT, or pleural effusion |
5 |
36 |
1.6
(1.3 to
1.9)
|
12% |
0.0
(0.0 to
0.71)
|
0% |
| in patients 40 or more, predisposing factor, suspected DVT, or pleural effusion |
24 |
38 |
1.3
(1.0 to
1.7)
|
39% |
0.46
(0.19 to
1.1)
|
18% |
| total |
34 |
118 |
- predisposing factor:
- history of recent surgery or trauma
- cancer
- CCF
- oral contraceptive use
- pregnancy
- history of venous thromboembolism
Comments
- No individual clinical sign or symptom was found to be useful.
Citation
-
Hull
RD,
Raskob
GE,
Carter
CJ, et al:
Pulmonary embolism in outpatients with pleuritic chest pain.
Archives of Internal Medicine
1988;
148:
838-844
Contributor: Chris Ball and Clare Wotton,
October 2000
Reviewer:
Clinical Question.
| Patient |
pleuritic pain |
| Intervention or Exposure |
clinical signs and symptoms |
| Outcome |
diagnosis of pulmonary embolism |
|
|